Skip to main content

Cornell University

PORTENT

A Center for Point of Care Technologies for Nutrition, Infection and Cancer

Educational Resources

The Global Health Point-of-Care Diagnostics Accelerator builds on the expertise within the L2M network and focuses on the development of go-to-market strategies for the PORTENT cohort. See our video resources below.

2025-26 PORTENT Global Health Point-of-Care Diagnostics Accelerator Program

Innovating Point of Care Diagnostics and Medical Device Software for Global Health:
Key Considerations for Regulatory Compliance
Kenneth Fuh
Senior Regulatory Affairs Consultants, Co-Founder & Director, Product Development at Syantra
Introduction to Value Proposition:
Dipika Matthias
Principle Strategy Consultant at NutriHealth Global Strategies and Member of PORTENT External Advisory Board
Setting the Stage:
Introduction to Commercialization and Path to Market in LMICs, Lara Vojnov
Chief Scientist & Independent Consultant
Global Health Impact Group

Regulatory Considerations:
WHO Prequalification and Alternate Paths
Robyn Meurant
Principal Consultant at ACT-IVD

2024-25 PORTENT Global Health Point-of-Care Diagnostics Accelerator Program

Overview of PORTENT L2M Workshops
PORTENT Team, November 12, 2024.
Path-to-Market in LMIC for POCD 2025
Lara Vojnov, PhD, The Global Health Impact Group, Chief Scientist, December 3, 2024.
Overview of Needs Assessment
Nikita Pant Pai, MD, PhD, McGill University, Needs Assessment Lead, Hani Rukh-E-Qamar, MSc, Varun Mohan, MBA, & Zaneta D’Souza, MDS, Needs Assessment Team, January 14, 2025.
Pixels to Profit: Revenue Models in Health Tech Imaging
Alexander Kagen, Mt. Sinai West | Mt. Sinai Morningside
Site Chair of Diagnostic, Molecular and Interventional Radiology, April 15, 2025
Regulatory Strategy in LMIC
Robyn Meurant, ACT-IVD Principal Consultant, March 18, 2025.

2023-24 PORTENT Global Health Point-of-Care Diagnostics Accelerator Program

The Role of Intellectual Property for Life Science Companies in Low and Mid-Resourced Markets
Philip Braginski, JD, Tartar, Krinsky & Drogin, Partner, Co-Chair of Life Sciences and China & India Practice, May 15, 2024.
Needs Assessment – an essential step in developing, validating and scaling up of POCT: Why & What
Nitika Pai, PhD and Varun Mohan, MBA, McGill University, Dissemination and Training, May 14, 2024.
Development of POCD Technologies in Low-Resource Settings
Aggrey Semeere, MBChB, M.med, MAS, Infectious Disease Institute, Clinical Site Lead, Uganda, May 14, 2024.
Practical Considerations for Developing Sustainable Diagnostics in LMICs
Leonard Peruski, PhD, Wadsworth Center, NYS Health Department, Director, May 14, 2024.
Context-Specific Considerations for Developing POCD
Tivani Mashamba-Thompson, PhD, University of Pretoria, External Advisory Board, May 14, 2024.
Setting the Stage: Path to Market Lara Vojnov, PhD, Chief Scientist, The Global Health Impact Group, May 14, 2024.
Using Pan-Pathogen Genomics Tools to Provide the Data Needed to Produce Fieldable Diagnostics
J. Kenneth Wickiser, PhD, Columbia University – Global Alliance for Preventing Pandemics, Administrative Director, May 14, 2024.